Modernizing dual antiplatelet therapy in flow diversion: comparative outcomes after transition to universal prasugrel

Prasugrel showed comparable safety and occlusion outcomes relative to clopidogrel and ticagrelor. Our findings underscore a critical gap in the evidence base and highlight the urgent need for multicenter registries and prospective trials to establish standardized, data-driven DAPT protocols for intracranial FD.